首页> 外文期刊>Heart rhythm: the official journal of the Heart Rhythm Society >Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.
【24h】

Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.

机译:晚期钠电流在调节奎尼丁的心律失常和抗心律失常作用中的作用。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Quinidine is used to treat atrial fibrillation and ventricular arrhythmias. However, at low concentrations, it can induce torsade de pointes (TdP). OBJECTIVE: The purpose of this study was to examine the role of late sodium current (I(Na)) as a modulator of the arrhythmogenicity of quinidine in female rabbit isolated hearts and cardiomyocytes. METHODS: Epicardial and endocardial monophasic action potentials (MAPs), ECG signals, and ion channel currents were measured. The sea anemone toxin ATX-II was used to increase late I(Na). RESULTS: Quinidine had concentration-dependent and often biphasic effects on measures of arrhythmogenicity. Quinidine increased the duration of epicardial MAP (MAPD(90)), QT interval, transmural dispersion of repolarization (TDR), and ventricular effective refractory period. Beat-to-beat variability of MAPD(90) (BVR), the interval from peak to end of the T wave (Tpeak-Tend) and index of Tpeak-Tend/QT interval were greater at 0.1 to 3 micromol/L than at 10-30 micromol/L quinidine. In the presence of 1 nmol/L ATX-II, quinidine caused significantly greater concentration-dependent and biphasic changes of Tpeak-Tend, TDR, BVR, and index of Tpeak-Tend/QT interval. Quinidine (1 micromol/L) induced TdP in 2 and 13 of 14 hearts in the absence and presence of ATX-II, respectively. Increases of BVR, index of Tpeak-Tend/QT interval, and Tpeak-Tend were associated with quinidine-induced TdP. Quinidine inhibited I(Kr), peak I(Na), and late I(Na) with IC(50)s of 4.5 +/- 0.3 micromol/L, 11.0 +/- 0.7 micromol/L, and 12.0 +/- 0.7 micromol/L. CONCLUSION: Quinidine had biphasic proarrhythmic effects in the presence of ATX-II, suggesting that late I(Na) is a modulator of the arrhythmogenicity of quinidine. Enhancement of late I(Na) increased proarrhythmia caused by low but not high concentrations of quinidine.
机译:背景:奎尼丁用于治疗房颤和室性心律不齐。但是,在低浓度下,它可能会诱发尖峰扭转(TdP)。目的:本研究的目的是探讨晚期钠电流(I(Na))对奎尼丁在雌性家兔离体心脏和心肌细胞中致心律失常性的调节作用。方法:测量心外膜和心内膜单相动作电位(MAPs),ECG信号和离子通道电流。使用海葵毒素ATX-II来增加晚期I(Na)。结果:奎尼丁对心律失常性的测定具有浓度依赖性且常常是双相的。奎尼丁增加心外膜MAP的持续时间(MAPD(90)),QT间隔,跨壁复极分散(TDR)和心室有效不应期。 MAPD(90)(BVR)的逐搏变异性,T波的峰到末间隔(Tpeak-Tend)和Tpeak-Tend / QT间隔的指数在0.1至3 micromol / L时大于10-30微摩尔/升奎尼丁。在1 nmol / L ATX-II存在下,奎尼丁引起Tpeak-Tend,TDR,BVR和Tpeak-Tend / QT间隔指数的浓度依赖性和双相性明显更大的变化。在不存在和存在ATX-II的情况下,奎尼丁(1 micromol / L)分别在14个心脏中的2个和13个心脏中诱导TdP。 BVR的增加,Tpeak-Tend / QT间隔指数和Tpeak-Tend与奎尼丁诱导的TdP相关。奎尼丁抑制I(Kr),峰I(Na)和晚期I(Na),IC(50)分别为4.5 +/- 0.3 micromol / L,11.0 +/- 0.7 micromol / L和12.0 +/- 0.7微摩尔/升。结论:奎尼丁在ATX-II存在下具有双相性心律失常作用,表明晚期I(Na)是奎尼丁心律失常性的调节剂。晚期I(Na)增强会导致奎尼丁浓度低但不是高浓度引起的心律失常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号